Changes in Levels of Biomarkers Associated with Adipocyte Function and Insulin and Glucagon Kinetics During Treatment with Dapagliflozin Among Obese Type 2 Diabetes Mellitus Patients
Crossref DOI link: https://doi.org/10.1007/s40268-016-0137-9
Published Online: 2016-06-22
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Okamoto, Aki
Yokokawa, Hirohide
Sanada, Hironobu
Naito, Toshio
License valid from 2016-06-22